BlackThorn Enrolls First Patient in Ph2a Study of Lead Compound, BTRX-246040
24 Jul 2017 //
PRESS RELEASE
BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing
05 Jan 2017 //
PRESS RELEASE
24 Jul 2017 //
PRESS RELEASE
05 Jan 2017 //
PRESS RELEASE